Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo.

Abstract:

:Hepcidin controls systemic iron availability, and its excess contributes to the anemia of chronic diseases, the most prevalent anemia in hospitalized patients. We previously reported that heparins are efficient hepcidin inhibitors both in vitro and in vivo, but their anticoagulant activity limits therapeutic use. We studied nonanticoagulant heparins produced by N-acetylation and oxidation/reduction (glycol-split) that lost antithrombin-binding affinity. Four nonanticoagulant heparins inhibited hepcidin expression in hepatic HepG2 cells and primary hepatocytes. The 2 most potent ones used in mice suppressed liver hepcidin expression and serum hepcidin in 6 hours, with a significant decrease of spleen iron. This occurred also in lipopolysaccharide (LPS)-treated animals that mimic inflammation, as well as after chronic 1-week treatments, without evident adverse effects on coagulation. Heparin injections increased iron mobilization and facilitated the recovery from the anemia induced by heat-killed Brucella abortus, a model of inflammatory anemia. The heparins were used also in Bmp6(-/-) mice. A single dose of heparin reduced the already low level of hepcidin of these mice and prevented its induction by LPS. These nonanticoagulant compounds impair bone morphogenetic protein /sons of mothers against decapentaplegic signaling with no evident adverse effect in vivo, even when administered chronically. They may offer a strategy for the treatment of diseases with high hepcidin levels.

journal_name

Blood

journal_title

Blood

authors

Poli M,Asperti M,Naggi A,Campostrini N,Girelli D,Corbella M,Benzi M,Besson-Fournier C,Coppin H,Maccarinelli F,Finazzi D,Arosio P

doi

10.1182/blood-2013-07-515221

subject

Has Abstract

pub_date

2014-03-06 00:00:00

pages

1564-73

issue

10

eissn

0006-4971

issn

1528-0020

pii

blood-2013-07-515221

journal_volume

123

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.

    abstract::The ex vivo expansion of hematopoietic progenitors is a promising approach for accelerating the engraftment of recipients, particularly when cord blood (CB) is used as a source of hematopoietic graft. With the aim of defining the in vivo repopulating properties of ex vivo-expanded CB cells, purified CD34(+) cells were...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guenechea G,Segovia JC,Albella B,Lamana M,Ramírez M,Regidor C,Fernández MN,Bueren JA

    更新日期:1999-02-01 00:00:00

  • Hyaluronate-CD44 interactions can induce murine B-cell activation.

    abstract::CD44 is a widely distributed cell surface glycoprotein whose principal ligand has been identified as hyaluronic acid (HA), a major component of the extracellular matrix (ECM). Recent studies have demonstrated that activation through CD44 leads to induction of effector function in T cells and macrophages. In the curren...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rafi A,Nagarkatti M,Nagarkatti PS

    更新日期:1997-04-15 00:00:00

  • Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. The Transfusion Safety Study Group.

    abstract::Transfusions purportedly induce dysfunction of cell-mediated immunity in sickle cell anemia (SCA). We studied hematologic and lymphocytic indices in 173 human immunodeficiency virus (HIV)-negative subjects with SCA and 131 black controls. Children aged 1 to 7 years with SCA had leukocyte counts and percentages of gran...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Wong WY,Powars DR,Operskalski EA,Hassett J,Parker JW,Sarnaik S,Pegelow CH,Hilgartner MW,Johnson CS,Zhou Y

    更新日期:1995-04-15 00:00:00

  • Natural history of hereditary spherocytosis during the first year of life.

    abstract::Although hereditary spherocytosis (HS) is a common disorder of the red cell membrane, its clinical and biologic expression at birth and in early infancy has received little attention. In order to obtain insights into the natural history of HS during infancy, we studied 46 neonates, 39 from families in which 1 of the p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Delhommeau F,Cynober T,Schischmanoff PO,Rohrlich P,Delaunay J,Mohandas N,Tchernia G

    更新日期:2000-01-15 00:00:00

  • Prevalence of heterozygotes for hemochromatosis in the white population of the United States.

    abstract::In previous studies, the prevalence of HLA-linked hemochromatosis, thought to be the most common genetic illness in whites, has been estimated by identifying homozygotes in the population. Because not all homozygotes express the disease phenotypically, the accuracy of these estimates is uncertain. We analyzed the dist...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: McLaren CE,Gordeuk VR,Looker AC,Hasselblad V,Edwards CQ,Griffen LM,Kushner JP,Brittenham GM

    更新日期:1995-09-01 00:00:00

  • An in vitro model of erythroid egress in bone marrow.

    abstract::An in vitro system has been developed that mimics the passage of erythrocytes from the bone marrow to the circulation. Bone marrow egress and its proper regulation are vital physiologic processes. However, because of the inaccessibility of the marrow, it is difficult to evaluate the various factors important in contro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Waugh RE,Sassi M

    更新日期:1986-07-01 00:00:00

  • Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated.

    abstract::We studied the relationship between the production of the 23-Kd interleukin-1 receptor antagonist (IL-1ra) and IL-1 beta in cultures of human peripheral blood mononuclear cells (PBMC) using a specific radioimmunoassay for IL-1ra that had a sensitivity of 166 +/- 11 pg/mL. PBMC cultured without human serum made little ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Poutsiaka DD,Clark BD,Vannier E,Dinarello CA

    更新日期:1991-09-01 00:00:00

  • Integrin αIIbβ3 outside-in signaling.

    abstract::Integrin αIIbβ3 is a highly abundant heterodimeric platelet receptor that can transmit information bidirectionally across the plasma membrane, and plays a critical role in hemostasis and thrombosis. Upon platelet activation, inside-out signaling pathways increase the affinity of αIIbβ3 for fibrinogen and other ligands...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-03-773614

    authors: Durrant TN,van den Bosch MT,Hers I

    更新日期:2017-10-05 00:00:00

  • Plasma crosslinked fibrin polymers: quantitation based on tissue plasminogen activator conversion to D-dimer and measurement in normal and patients with acute thrombotic disorders.

    abstract::Plasma crosslinked fibrin polymers (XLFP) are formed as a result of in vivo hemostatic activation and are elevated in thrombotic disease. We have investigated the plasmic degradation of plasma XLFP in vitro to provide information regarding the pattern of crosslinking and the composition of degradation products. Plasma...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kornberg A,Francis CW,Marder VJ

    更新日期:1992-08-01 00:00:00

  • Lymphocyte aggregation in response to adrenergic stimulation.

    abstract::A nonanemic chronic lymphocytic leukemia patient with nearly 500,000 lymphocytes/microL underwent leukapheresis when she presented with CNS symptoms and retinal vascular engorgement. Respiratory distress developed during the cell separator run, which led us to ask whether the procedure could have changed the adhesive ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hammerschmidt DE,Jeanneret C,Husak M,Lobell M,Jacob HS

    更新日期:1988-05-01 00:00:00

  • Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.

    abstract::The absence of expanded numbers of hepatitis C virus (HCV)-reactive CD8(+) T lymphocytes (CTLs) in patients chronically infected with HCV has led to the investigation of dendritic cell (DC) function in this population as a potential cause for this defect. Several studies have shown evidence for impaired monocyte-deriv...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1339

    authors: Longman RS,Talal AH,Jacobson IM,Albert ML,Rice CM

    更新日期:2004-02-01 00:00:00

  • Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.

    abstract::The prevalence, the prognostic effect, and interaction with other molecular markers of DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger than 60 years. We show mutations in DNMT3A in 96 of 415 patients with newly diagnosed AML (23.1%). Univariate Cox regression analysis showed that...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-07-367961

    authors: Ribeiro AF,Pratcorona M,Erpelinck-Verschueren C,Rockova V,Sanders M,Abbas S,Figueroa ME,Zeilemaker A,Melnick A,Löwenberg B,Valk PJ,Delwel R

    更新日期:2012-06-14 00:00:00

  • Bedside filtration of blood products in the prevention of HLA alloimmunization--a prospective randomized study. Alloimmunisation Study Group.

    abstract::To test the efficacy of poststorage bedside leucodepletion of blood products in the prevention of primary HLA alloimmunization and its clinical sequelae, 172 patients with hematologic malignancy requiring intensive red blood cell and platelet support were randomized to receive either standard or filtered red blood cel...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Williamson LM,Wimperis JZ,Williamson P,Copplestone JA,Gooi HC,Morgenstern GR,Norfolk DR

    更新日期:1994-05-15 00:00:00

  • Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.

    abstract::Oncostatin M (OSM) and leukemia inhibitory factor (LIF) are members of the interleukin-6 (IL-6) subfamily of cytokines that use a common signal transducer gp130. Human OSM (hOSM) and LIF share a functional high-affinity receptor that is composed of gp130 and LIF receptor beta subunit (LIFRbeta). A second high-affinity...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ichihara M,Hara T,Kim H,Murate T,Miyajima A

    更新日期:1997-07-01 00:00:00

  • Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells.

    abstract::Human endothelial cells release two forms of a plasminogen activator-specific inhibitor: an active form that readily binds to and inhibits plasminogen activators and an inactive or latent form that has no anti-activator activity but which can be activated by denaturation. Latent and active forms of plasminogen activat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Levin EG

    更新日期:1986-05-01 00:00:00

  • Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia.

    abstract::Chromosome maintenance protein 1 (CRM1) is a nuclear export receptor involved in the active transport of tumor suppressors (e.g., p53 and nucleophosmin) whose function is altered in cancer because of increased expression and overactive transport. Blocking CRM1-mediated nuclear export of such proteins is a novel therap...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-04-423160

    authors: Ranganathan P,Yu X,Na C,Santhanam R,Shacham S,Kauffman M,Walker A,Klisovic R,Blum W,Caligiuri M,Croce CM,Marcucci G,Garzon R

    更新日期:2012-08-30 00:00:00

  • High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine.

    abstract::Although virtually all pediatric patients with acute myeloid leukemia (AML) achieve a complete remission after initial induction therapy, 30%-40% of patients will encounter a relapse and have a dismal prognosis. To prevent relapses, personalized treatment strategies are currently being developed, which target specific...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-03-276519

    authors: Bachas C,Schuurhuis GJ,Hollink IH,Kwidama ZJ,Goemans BF,Zwaan CM,van den Heuvel-Eibrink MM,de Bont ES,Reinhardt D,Creutzig U,de Haas V,Assaraf YG,Kaspers GJ,Cloos J

    更新日期:2010-10-14 00:00:00

  • TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation.

    abstract::Recent studies have identified several populations of progenitor cells in the human thymus. The hematopoietic precursor activity of these populations has been determined. The most primitive human thymocytes express high levels of CD34 and lack CD1a. These cells acquire CD1a and differentiate into CD4(+)CD8(+) through ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Blom B,Verschuren MC,Heemskerk MH,Bakker AQ,van Gastel-Mol EJ,Wolvers-Tettero IL,van Dongen JJ,Spits H

    更新日期:1999-05-01 00:00:00

  • High-dose cyclophosphamide for refractory autoimmune hemolytic anemia.

    abstract::High-dose cyclophosphamide, without stem cell rescue, has been used successfully to treat aplastic anemia and other autoimmune disorders. To determine the safety and efficacy of high-dose cyclophosphamide among patients with severe refractory autoimmune hemolytic anemia, we treated 9 patients with cyclophosphamide (50...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2002-01-0087

    authors: Moyo VM,Smith D,Brodsky I,Crilley P,Jones RJ,Brodsky RA

    更新日期:2002-07-15 00:00:00

  • Expression and function of adhesion molecules on human hematopoietic stem cells: CD34+ LFA-1- cells are more primitive than CD34+ LFA-1+ cells.

    abstract::Advances in fluorescence-activated cell sorter technology have brought about multicolor analysis of cell phenotypes. To clarify the phenotypes of human hematopoietic stem cells (HSCs), we initially prepared novel antibodies against CD34 and labeled one of them (4A1) with allophycocyanin (APC). With this, we analyzed t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gunji Y,Nakamura M,Hagiwara T,Hayakawa K,Matsushita H,Osawa H,Nagayoshi K,Nakauchi H,Yanagisawa M,Miura Y

    更新日期:1992-07-15 00:00:00

  • A randomized comparison of two doses of human lymphoblastoid interferon-alpha in hairy cell leukemia. Wellcome HCL Study Group.

    abstract::One hundred thirty-eight patients with hairy cell leukemia were randomized to receive either a dose of 2.0 megaunits (MU)/m2 or a 10-fold lower dose of 0.2 MU/m2 of a highly purified natural alpha-interferon, administered daily for 28 days followed by a three times a week schedule. Ninety-seven of these patients had p...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Smalley RV,Anderson SA,Tuttle RL,Connors J,Thurmond LM,Huang A,Castle K,Magers C,Whisnant JK

    更新日期:1991-12-15 00:00:00

  • Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblasts.

    abstract::We have examined the in vitro effects of recombinant human (rh) interleukin-1 (IL-1) on the growth of purified megakaryoblasts obtained from patients with acute megakaryoblastic leukemia. We demonstrate that both IL-1 alpha and IL-1 beta treatment of these cells led to stimulation of DNA synthesis (as shown by increas...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Brach MA,Löwenberg B,Mantovani L,Schwulera U,Mertelsmann R,Herrmann F

    更新日期:1990-11-15 00:00:00

  • High numbers of CD4+ T cells showing abnormal recognition of DR antigens in lymphoid organs involved by Hodgkin's disease.

    abstract::Purified T lymphocytes (E rosetting cells) isolated from the involved lymphoid organs (lymph nodes and spleen) of five patients with Hodgkin's disease (HD) were cloned under culture conditions (phytohemagglutinin plus interleukin-2) that allow clonal expansion of most T lymphocytes. A total number of 104 CD4+ T cell c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Maggi E,Parronchi P,Macchia D,Bellesi G,Romagnani S

    更新日期:1988-05-01 00:00:00

  • Regulation of steady-state neutrophil homeostasis by macrophages.

    abstract::The timely clearance of apoptotic neutrophils from inflammation sites is an important function of macrophages; however, the role of macrophages in maintaining neutrophil homeostasis under steady-state conditions is less well understood. By conditionally deleting the antiapoptotic gene cellular FLICE-like inhibitory pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-265959

    authors: Gordy C,Pua H,Sempowski GD,He YW

    更新日期:2011-01-13 00:00:00

  • Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase C-gamma 1 pathways.

    abstract::Receptor tyrosine kinases are known to be important in growth and differentiation. We have recently found that c-kit, the tyrosine kinase receptor for steel factor, also regulates cell-matrix adhesion. Because Steel factor helps regulate cell migration and localization, this may be an important biologic function. Inte...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kinashi T,Escobedo JA,Williams LT,Takatsu K,Springer TA

    更新日期:1995-09-15 00:00:00

  • CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.

    abstract::Lipopolysaccharide (LPS) is a major gram-negative bacterial component that stimulates innate immune response and also induces B-lymphocyte activation. Recent studies have revealed that common molecular patterns of microorganisms such as LPS are recognized by toll-like receptors (TLRs). B cells have 2 known TLRs that m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-11-3573

    authors: Yazawa N,Fujimoto M,Sato S,Miyake K,Asano N,Nagai Y,Takeuchi O,Takeda K,Okochi H,Akira S,Tedder TF,Tamaki K

    更新日期:2003-08-15 00:00:00

  • Expression of Pitx2 in stromal cells is required for normal hematopoiesis.

    abstract::Although the expression of Pitx2, a bicoid family homeodomain transcription factor, is highly regulated during hematopoiesis, its function during this process was not documented; we thus studied hematopoiesis in Pitx2-null mice. We found that Pitx2(-/-) embryos display hypoplastic livers with reduced numbers of hemato...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0529

    authors: Kieusseian A,Chagraoui J,Kerdudo C,Mangeot PE,Gage PJ,Navarro N,Izac B,Uzan G,Forget BG,Dubart-Kupperschmitt A

    更新日期:2006-01-15 00:00:00

  • Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.

    abstract::The leukemia-specific AML1/ETO fusion gene has been shown to be detected by reverse transcriptase polymerase chain reaction (RT-PCR) analysis in patients with t(8;21) acute myelogenous leukemia (AML) in long-term remission. In the present study, the AML1/ETO mRNA could be detected by RT-PCR in bone marrow (BM) and/or ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miyamoto T,Nagafuji K,Akashi K,Harada M,Kyo T,Akashi T,Takenaka K,Mizuno S,Gondo H,Okamura T,Dohy H,Niho Y

    更新日期:1996-06-01 00:00:00

  • Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease.

    abstract::Adhesive interactions between circulating sickle red blood cells (RBCs), leukocytes, and endothelial cells are major pathophysiologic events in sickle cell disease (SCD). To develop new therapeutics that efficiently inhibit adhesive interactions, we generated an anti-P-selectin aptamer and examined its effects on cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-285718

    authors: Gutsaeva DR,Parkerson JB,Yerigenahally SD,Kurz JC,Schaub RG,Ikuta T,Head CA

    更新日期:2011-01-13 00:00:00

  • Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy.

    abstract::In the phase 3 Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE), at 1 year, eliglustat was noninferior to imiglucerase enzyme therapy in maintaining stable platelet counts, hemoglobin concentrations, and spleen and l...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2016-12-758409

    authors: Cox TM,Drelichman G,Cravo R,Balwani M,Burrow TA,Martins AM,Lukina E,Rosenbloom B,Goker-Alpan O,Watman N,El-Beshlawy A,Kishnani PS,Pedroso ML,Gaemers SJM,Tayag R,Peterschmitt MJ

    更新日期:2017-04-27 00:00:00